← Oncology Approval Tracker

FDA DECISION ·

Imkeldi

imatinib mesylate · Shorla Oncology

FDA approvalNew formulationLeukemias, GIST and other selected tumors
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Oral solution for specified imatinib indications, including Philadelphia chromosome-positive CML and ALL, PDGFR-rearranged MDS/MPD, selected systemic mastocytosis and eosinophilic disorders, dermatofibrosarcoma protuberans, and KIT-positive gastrointestinal stromal tumors. Age, prior treatment and biomarker requirements depend on the indication.

LAMPGEN ANALYSIS

Why it matters

A ready-to-administer liquid adds an option for patients who have difficulty taking tablets, including children in the applicable leukemia settings.

What research teams should watch

Use the concentration and oral syringe in dosing instructions, and reconcile milligrams and milliliters at every transition of care.

PRIMARY RECORDS

Sources